The recent progress of γδ T cells and its targeted therapies in rheumatoid arthritis

被引:0
|
作者
Feng, Xue [1 ]
Xu, Yan [1 ]
机构
[1] Jilin Univ, Bethune Hosp 1, Dept Bone & Joint Surg, Changchun 130000, Peoples R China
关键词
lymphocyte; rheumatic disease; rheumatoid arthritis; T cell; gamma delta T cells; COLLAGEN-INDUCED ARTHRITIS; SYNOVIAL-FLUID; TCR; RECEPTOR; INFILTRATION; EXACERBATION; PATHOGENESIS; STIMULATION; INVOLVEMENT; LYMPHOCYTES;
D O I
10.1111/1756-185X.15381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is an autoimmune condition that mostly impacts the joints. During the advanced phases of the disorder, it may be accompanied by other problems. While the precise cause of RA is uncertain, various research has been conducted to gain a better understanding of the immunological processes involved in the development of RA. T cells are acknowledged as significant contributors to the progression of RA because of their roles in cytokine secretion, antigen presentation, and facilitating B cells in the manufacture of antibodies. gamma delta T cells are a small subset of T cells that have significant functions in the context of infection and diseases linked with tumors. gamma delta T cells have been the subject of investigation in autoimmune disorders in recent years. This review focused on the involvement of gamma delta T lymphocytes in the development of RA. In this article, we provide an analysis of the immunological capabilities of gamma delta T cells, intending to comprehend their significance in RA, which could be pivotal in the creation of innovative clinical treatments.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] T-cell-targeted therapies in rheumatoid arthritis
    Cornelia M Weyand
    Jörg J Goronzy
    Nature Clinical Practice Rheumatology, 2006, 2 : 201 - 210
  • [2] T-cell-targeted therapies in rheumatoid arthritis
    Weyand, CM
    Goronzy, JJ
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (04): : 201 - 210
  • [3] TARGETED THERAPIES FOR RHEUMATOID ARTHRITIS: A REVIEW
    Lama, Anju
    Saikia, Hiteswar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (05): : 1116 - 1134
  • [4] The development of targeted therapies in rheumatoid arthritis
    Vital, Edward M.
    Emery, Paul
    JOURNAL OF AUTOIMMUNITY, 2008, 31 (03) : 219 - 227
  • [5] Targeted therapies in rheumatoid arthritis: Focus on rituximab
    Teng, Y. K. O.
    Huizinga, T. W. J.
    van Laar, J. M.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 325 - 333
  • [6] Glucocorticoids for rheumatoid arthritis in the era of targeted therapies
    Boers, Maarten
    REUMATOLOGIA CLINICA, 2019, 15 (06): : 311 - 314
  • [7] Targeted therapies in rheumatoid arthritis: the need for action
    Emery, P
    Panayi, G
    Sturrock, R
    Williams, B
    RHEUMATOLOGY, 1999, 38 (10) : 911 - 912
  • [8] Using targeted therapies alone for rheumatoid arthritis
    Prati, Clement
    Wendling, Daniel
    JOINT BONE SPINE, 2011, 78 (01) : 1 - 3
  • [9] Biological Therapies for Rheumatoid Arthritis: Progress to Date
    Malviya, Gaurav
    Salemi, Simonetta
    Lagana, Bruno
    Diamanti, Andrea Picchianti
    D'Amelio, Raffaele
    Signore, Alberto
    BIODRUGS, 2013, 27 (04) : 329 - 345
  • [10] Biological Therapies for Rheumatoid Arthritis: Progress to Date
    Gaurav Malviya
    Simonetta Salemi
    Bruno Laganà
    Andrea Picchianti Diamanti
    Raffaele D’Amelio
    Alberto Signore
    BioDrugs, 2013, 27 : 329 - 345